With regard to the A7450 T1 M1+ chemo group, there was a trend towards longer progression-free survival, yet this did not reach statistical significance (hazard ratio: 0.9).
← all excerpts
In vivo vaccination with cell line-derived whole tumor lysates: neoantigen quality, not quantity matters.
1
—
—